Tómasson K, Vaglum P
Department of Psychiatry, National University Hospital, Reykjavík, Iceland.
Acta Psychiatr Scand. 1995 Nov;92(5):378-85. doi: 10.1111/j.1600-0447.1995.tb09600.x.
In order to elucidate the psychiatric comorbidity of patients in alcohol and other substance use disorder treatment we examined a representative sample of such patients in Iceland (249 men and 102 women). Over 70% of pure alcoholics and over 90% of polysubstance users had comorbid diagnoses, a prevalence higher than in the Epidemiological Catchment Area study in the United States, but similar to clinical studies from North America. The most prevalent disorders were: affective (33%), anxiety (65%), antisocial personality disorder (28%) and psychosexual dysfunction (20%). Pure alcoholics and polysubstance users in studies on psychiatric comorbidity should be separated. Anxiety and affective disorders influence treatment seeking. Findings concerning the impact of psychiatric comorbidity on course should be comparable between North America and Europe.
为了阐明酒精及其他物质使用障碍治疗患者的精神疾病共病情况,我们对冰岛的这类患者进行了代表性抽样研究(249名男性和102名女性)。超过70%的单纯酒精成瘾者和超过90%的多种物质使用者患有共病诊断,这一患病率高于美国的流行病学集水区研究,但与北美的临床研究相似。最常见的疾病有:情感障碍(33%)、焦虑症(65%)、反社会人格障碍(28%)和性心理功能障碍(20%)。关于精神疾病共病的研究中,单纯酒精成瘾者和多种物质使用者应分开。焦虑症和情感障碍会影响寻求治疗的行为。关于精神疾病共病对病程影响的研究结果在北美和欧洲应具有可比性。